Home/Investors/ARTIS Ventures

ARTIS Ventures

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

7

Top Stage

Commercial

Investment Focus

Cardiovascular Disease Pulmonary Disease Infectious Disease Genetic Disorders Hematology Cell Therapy Regenerative Medicine

Portfolio Companies

Company	Stage	Valuation	Focus
Eko Devices	Commercial	—	Cardiovascular Disease, Pulmonary Disease
Excision BioTherapeutics	Phase 1	—	Infectious Disease, Genetic Disorders
Garuda Therapeutics	preclinical	—	Hematology, Cell Therapy

Frequent Co-Investors

Northpond Ventures1 shared Alexandria Venture Investments1 shared Redmile Group1 shared Norwest Venture Partners1 shared Adjuvant Capital1 shared Leaps by Bayer1 shared DigiTx Partners1 shared 3M Ventures1 shared